Deutsche Bank’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Buy
89,975
+15,772
+21% +$220K ﹤0.01% 1803
2025
Q4
$657K Buy
74,203
+15,054
+25% +$130K ﹤0.01% 2423
2025
Q3
$497K Buy
59,149
+6,488
+12% +$43.9K ﹤0.01% 2544
2025
Q2
$270K Sell
52,661
-1,127
-2% -$2.79K ﹤0.01% 2797
2025
Q1
$73.7K Buy
53,788
+17,135
+47% +$42.1K ﹤0.01% 3292
2024
Q4
$113K Buy
36,653
+7,128
+24% +$33.1K ﹤0.01% 3258
2024
Q3
$227K Buy
29,525
+7,025
+31% +$67K ﹤0.01% 2863
2024
Q2
$193K Buy
22,500
+2,157
+11% +$16.7K ﹤0.01% 2824
2024
Q1
$162K Sell
20,343
-4,286
-17% -$45.9K ﹤0.01% 2947
2023
Q4
$244K Sell
24,629
-560
-2% -$4.86K ﹤0.01% 2762
2023
Q3
$284K Sell
25,189
-173
-0.7% -$1.05K ﹤0.01% 2547
2023
Q2
$84.2K Sell
25,362
-8,596
-25% -$30.9K ﹤0.01% 3345
2023
Q1
$134K Buy
33,958
+9,790
+41% +$56.8K ﹤0.01% 3196
2022
Q4
$175K Buy
24,168
+5,231
+28% +$36.8K ﹤0.01% 3049
2022
Q3
$69K Sell
18,937
-3,112
-14% -$13.3K ﹤0.01% 3491
2022
Q2
$100K Buy
+22,049
New +$134K ﹤0.01% 3525
2020
Q4
Sell
-7,598
Closed -$79K 4527
2020
Q3
$79K Buy
+7,598
New +$77.6K ﹤0.01% 3659

Other funds holding TNGX

Deutsche Bank's TNGX Position: Q1 2026 in Review

Deutsche Bank increased its Tango Therapeutics (TNGX) stake by 21% in Q1 2026, buying an estimated $220K and bringing the position to 89,975 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Deutsche Bank first reported a position in TNGX in Q3 2020 and has held it in 17 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Deutsche Bank held 89,975 shares of Tango Therapeutics worth $1.88M as of Q1 2026.
  • Deutsche Bank bought 15,772 Tango Therapeutics shares in Q1 2026, an estimated $220K.
  • Tango Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1803 holding.
  • Deutsche Bank first reported a position in Tango Therapeutics in Q3 2020 and has held it in 17 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.